Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy
about
Discovery of Inhibitors of 4'-Phosphopantetheine Adenylyltransferase (PPAT) To Validate PPAT as a Target for Antibacterial TherapyOptimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of TuberculosisTricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agentsA novel high-throughput cell-based assay aimed at identifying inhibitors of DNA metabolism in bacteriaDiscovery of ATP-Competitive Inhibitors of tRNAIle Lysidine Synthetase (TilS) by High-Throughput Screening.Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design.Discovery of Novel Mycobacterial DNA Gyrase B Inhibitors: In Silico and In Vitro Biological Evaluation.The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.Thermodynamic computational approach to capture molecular recognition in the binding of different inhibitors to the DNA gyrase B subunit from Escherichia coli.Design, synthesis, and biological evaluation of 1-ethyl-3-(thiazol-2-yl)urea derivatives as Escherichia coli DNA gyrase inhibitors.Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors.Docking Studies in Target Proteins Involved in Antibacterial Action Mechanisms: Extending the Knowledge on Standard Antibiotics to Antimicrobial Mushroom CompoundsSynthesis and evaluation of original bioisosteres of bacterial type IIA topoisomerases inhibitors
P2860
Q27679964-D2FF3963-A56D-4961-9BCB-AF11CF4CDD9BQ27680342-0B85AF90-B509-4C4C-96D6-0D456107D70AQ28538023-24337E1E-BAC2-415C-BD4C-8D5DC83B5DE7Q30410098-02F5FE86-A5D0-421F-BFD8-A286AA06FB32Q35167286-0174B5E5-8669-42DB-8B44-9CBF7007FCF3Q35994500-BCA0BEE0-A5BD-4996-9154-13933C943B47Q36093500-F11CB2AF-74F6-46EA-B1AB-F6C6D45C8413Q40558328-CF156442-D1B1-4C6E-8324-A7FF18485642Q45717201-B34D1313-4A0A-4F46-9B76-15DCBC13F150Q48120268-C4168D7E-6D17-4366-A343-44EF88147F6DQ48175813-453CB75B-AA2E-49B6-A055-359A0652BE5AQ48266288-E5070E91-17FF-42AE-A202-20BE9DB13EAAQ57757644-C7A1C51E-2370-4592-B2AB-6E3EC3E2BAF1Q57978651-7A3934F5-ED0A-4A13-A202-C9BB89F55DB2
P2860
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy
@ast
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy
@en
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy
@nl
type
label
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy
@ast
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy
@en
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy
@nl
prefLabel
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy
@ast
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy
@en
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy
@nl
P2093
P1476
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy
@en
P2093
Ann Boriack-Sjodin
Ann E Eakin
Brian A Sherer
George Mullen
Gregory Basarab
James T Loch
Joanna Bryant
Kenneth Hull
Maria Uria-Nickelsen
P304
P356
10.1016/J.BMCL.2011.10.010
P407
P577
2011-12-15T00:00:00Z